Skip navigation

DAY ONE | THURSDAY, JANUARY 24, 2019

7:30

Workshop Registration and Continental Breakfast

8:30

WORKSHOP Understand How Integrated Delivery Networks [IDNs] Impact Cost and Access to Specialty Therapies

I. Review the key components of the IDN Model of patient care coordination

II. Review the key components of the IDN Model of patient care coordination

III. Examine best practices for working with IDNs

Workshop Leaders:

Timothy Paine
Director, Industry Relations
Fairview Specialty Pharmacy

Jacob A. Jolly
Program Director, Specialty Pharmacy
Vanderbilt University Medical Center

Cole Wilson
Assistant Vice President, Division of Pharmacy Services
Atrium Health

Patrick J. Sorgen
Manager, Pharmacy Department
Indiana University Health

There will be a 30-minute networking and refreshment break at 10:00am

12:00

Close of Workshop; Conference Registration and Refreshments

MAIN CONFERENCE

12:00

Main Conference Registration

1:00

Chairperson’s Welcome and Opening Remarks

Sheena Farragut Babin, PharmD, CSP
Manager, Business Development and Clinical Services
Ochsner Health System

1:15

The Drug Supply Chain Shakeup and What it Means

Steven G. Avey, MS, RPh, FAMCP
Vice President, Specialty Pharmacy Strategy
MedImpact Health Systems, Inc.

Examine the Evolving Role of Specialty Pharmacies and the Impact of Patient Engagement on Overall Medical Costs

2:00

Assess the Value of Coordinated Care in the Health Systems and Specialty Pharmacy Model

Jacob A. Jolly
Program Director, Specialty Pharmacy
Vanderbilt University Medical Center

Patrick J. Sorgen
Manager, Pharmacy Department
Indiana University Health

2:45

Networking and Refreshment Break

3:15

Examine the Recently Approved and Emerging Oncology Pipeline

Cheryl Allen, BS Pharm, MBA
Vice President, Industry Relations
Diplomat

4:00

Understand Prescriber Needs, Challenges and Opportunities to Improve the Specialty Medications Prescribing Process

Kathy Lewis, MPH
Director, Product Innovation
Surescripts

Pooja Babbrah, MBA
Practice Lead, PBM Services
Point-of-Care Partners

4:45

Addressing Biosimilars Barriers to Entry

Timothy Paine
Director, Industry Relations
Fairview Specialty Pharmacy

5:30

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO | FRIDAY, JANUARY 25, 2019

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Sheena Farragut Babin, PharmD, CSP
Manager, Business Development and Clinical Services
Ochsner Health System

Consider the Potential Impact of Copay Accumulators,
Drug Pricing Transparency Legislation and
Biosimilars on Specialty Therapy Access

8:45

Deploying an Evidence Based Medicine Model to Drive Better Rx Outcomes

Kristin Begley, PharmD
former Chief Commercial Officer, EmpiRx Health;
Principal, All Tru Health

Pramod John
CEO
VIVIO Health

9:30

Table Talk Breakout Sessions

Neil Shah, PharmD
Specialty Pharmacist
Blue Cross Blue Shield North Carolina

10:15

Networking and Refreshment Break

10:45

Legislative Update

Mark D. Boesen, PharmD, JD, FAzPA
Senior Partner
Boesen & Snow Law

11:30

Examine the Rise of Copay Accumulator Programs

Charles E. Collins, Jr., MS, MBA
President
Healthcare Stakeholder Solutions, LLC

12:15

Networking Luncheon

Assess the Evolution of Data Standardization and
the Biosimilars Pipeline

1:30

Implement Models for Improving Patient Engagement and Adherence for Better Outcomes

Sheena Farragut Babin, PharmD, CSP
Manager, Business Development and Clinical Services
Ochsner Health System

2:15

Supporting Better Data Sharing Across the Value Chain

Carly Rodriguez
Pharmacy Director, Clinical Innovation
Moda Health

Grant E. Knowles, PharmD, CSP
VP, Business Development
Ardon Health

3:00

Close of Conference

Want more agenda details? Download the brochure.

DAY ONE | THURSDAY, JANUARY 24, 2019

7:30

Workshop Registration and Continental Breakfast

8:30

WORKSHOP Understand How Integrated Delivery Networks [IDNs] Impact Cost and Access to Specialty Therapies

I. Review the key components of the IDN Model of patient care coordination

II. Review the key components of the IDN Model of patient care coordination

III. Examine best practices for working with IDNs

Workshop Leaders:

Timothy Paine
Director, Industry Relations
Fairview Specialty Pharmacy

Jacob A. Jolly
Program Director, Specialty Pharmacy
Vanderbilt University Medical Center

Cole Wilson
Assistant Vice President, Division of Pharmacy Services
Atrium Health

Patrick J. Sorgen
Manager, Pharmacy Department
Indiana University Health

There will be a 30-minute networking and refreshment break at 10:00am

12:00

Close of Workshop; Conference Registration and Refreshments

MAIN CONFERENCE

12:00

Main Conference Registration

1:00

Chairperson’s Welcome and Opening Remarks

Sheena Farragut Babin, PharmD, CSP
Manager, Business Development and Clinical Services
Ochsner Health System

1:15

The Drug Supply Chain Shakeup and What it Means

Steven G. Avey, MS, RPh, FAMCP
Vice President, Specialty Pharmacy Strategy
MedImpact Health Systems, Inc.

Examine the Evolving Role of Specialty Pharmacies and the Impact of Patient Engagement on Overall Medical Costs

2:00

Assess the Value of Coordinated Care in the Health Systems and Specialty Pharmacy Model

Jacob A. Jolly
Program Director, Specialty Pharmacy
Vanderbilt University Medical Center

Patrick J. Sorgen
Manager, Pharmacy Department
Indiana University Health

2:45

Networking and Refreshment Break

3:15

Examine the Recently Approved and Emerging Oncology Pipeline

Cheryl Allen, BS Pharm, MBA
Vice President, Industry Relations
Diplomat

4:00

Understand Prescriber Needs, Challenges and Opportunities to Improve the Specialty Medications Prescribing Process

Kathy Lewis, MPH
Director, Product Innovation
Surescripts

Pooja Babbrah, MBA
Practice Lead, PBM Services
Point-of-Care Partners

4:45

Addressing Biosimilars Barriers to Entry

Timothy Paine
Director, Industry Relations
Fairview Specialty Pharmacy

5:30

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO | FRIDAY, JANUARY 25, 2019

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Sheena Farragut Babin, PharmD, CSP
Manager, Business Development and Clinical Services
Ochsner Health System

Consider the Potential Impact of Copay Accumulators,
Drug Pricing Transparency Legislation and
Biosimilars on Specialty Therapy Access

8:45

Deploying an Evidence Based Medicine Model to Drive Better Rx Outcomes

Kristin Begley, PharmD
former Chief Commercial Officer, EmpiRx Health;
Principal, All Tru Health

Pramod John
CEO
VIVIO Health

9:30

Table Talk Breakout Sessions

Neil Shah, PharmD
Specialty Pharmacist
Blue Cross Blue Shield North Carolina

10:15

Networking and Refreshment Break

10:45

Legislative Update

Mark D. Boesen, PharmD, JD, FAzPA
Senior Partner
Boesen & Snow Law

11:30

Examine the Rise of Copay Accumulator Programs

Charles E. Collins, Jr., MS, MBA
President
Healthcare Stakeholder Solutions, LLC

12:15

Networking Luncheon

Assess the Evolution of Data Standardization and
the Biosimilars Pipeline

1:30

Implement Models for Improving Patient Engagement and Adherence for Better Outcomes

Sheena Farragut Babin, PharmD, CSP
Manager, Business Development and Clinical Services
Ochsner Health System

2:15

Supporting Better Data Sharing Across the Value Chain

Carly Rodriguez
Pharmacy Director, Clinical Innovation
Moda Health

Grant E. Knowles, PharmD, CSP
VP, Business Development
Ardon Health

3:00

Close of Conference